As a member of the firm’s M&A group, Ro guides his clients through high-stakes public and private mergers and acquisitions, venture capital financings, and securities offerings representing an aggregate value of more than $224 billion. He focuses on cutting-edge technology and biotechnology transactions, and is one of the go-to M&A advisers for complex cross-border transactions in these fields. Ro also regularly advises boards of directors and special committees on activist defense, proxy contests, and corporate governance matters.
Download full bio